首页> 美国卫生研究院文献>Frontiers in Chemistry >Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling
【2h】

Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling

机译:高血压发展过程中抵抗力动脉中的蛋白质二硫键异构酶表达增加。对Nox1 NADPH氧化酶信号转导的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

NADPH oxidases derived reactive oxygen species (ROS) play an important role in vascular function and remodeling in hypertension through redox signaling processes. Previous studies demonstrated that protein disulfide isomerase (PDI) regulates Nox1 expression and ROS generation in cultured vascular smooth muscle cells. However, the role of PDI in conductance and resistance arteries during hypertension development remains unknown. The aim of the present study was to investigate PDI expression and NADPH oxidase dependent ROS generation during hypertension development. Mesenteric resistance arteries (MRA) and thoracic aorta were isolated from 6, 8, and 12 week-old spontaneously hypertensive (SHR) and Wistar rats. ROS production (dihydroethidium fluorescence), PDI (WB, imunofluorescence), Nox1 and NOX4 (RT-PCR) expression were evaluated. Results show a progressive increase in ROS generation in MRA and aorta from 8 to 12 week-old SHR. This effect was associated with a concomitant increase in PDI and Nox1 expression only in MRA. Therefore, suggesting a positive correlation between PDI and Nox1 expression during the development of hypertension in MRA. In order to investigate if this effect was due to an increase in arterial blood pressure, pre hypertensive SHR were treated with losartan (20 mg/kg/day for 30 days), an AT1 receptor antagonist. Losartan decreased blood pressure and ROS generation in both vascular beds. However, only in SHR MRA losartan treatment lowered PDI and Nox1 expression to control levels. In MRA PDI inhibition (bacitracin, 0.5 mM) decreased Ang II redox signaling (p-ERK 1/2). Altogether, our results suggest that PDI plays a role in triggering oxidative stress and vascular dysfunction in resistance but not in conductance arteries, increasing Nox1 expression and activity. Therefore, PDI could be a new player in oxidative stress and functional alterations in resistance arteries during the establishment of hypertension.
机译:NADPH氧化酶衍生的活性氧(ROS)通过氧化还原信号传导过程在高血压的血管功能和重塑中起重要作用。先前的研究表明,蛋白质二硫键异构酶(PDI)调节培养的血管平滑肌细胞中Nox1的表达和ROS的产生。然而,PDI在高血压发展过程中在电导和阻力动脉中的作用仍然未知。本研究的目的是研究高血压发展过程中PDI表达和NADPH氧化酶依赖性ROS的产生。从6、8和12周龄自发性高血压(SHR)和Wistar大鼠中分离出肠系膜阻力动脉(MRA)和胸主动脉。评估了ROS的产生(二氢乙啶荧光),PDI(WB,免疫荧光),Nox1和NOX4(RT-PCR)的表达。结果显示,从8周龄到12周龄SHR,MRA和主动脉中ROS的产生逐渐增加。仅在MRA中,该作用与PDI和Nox1表达的同时增加有关。因此,提示MRA高血压发展过程中PDI与Nox1表达呈正相关。为了研究这种作用是否是由于动脉血压升高引起的,高血压前SHR用氯沙坦(20毫克/千克/天,持续30天)治疗,这是一种AT1受体拮抗剂。氯沙坦降低了两个血管床的血压和活性氧生成。然而,仅在SHR MRA中,氯沙坦治疗可将PDI和Nox1表达降低至对照水平。在MRA中,PDI抑制(杆菌肽,0.5 mM)降低了Ang II氧化还原信号(p-ERK 1/2)。总而言之,我们的研究结果表明,PDI在触发抗性中的氧化应激和血管功能障碍中起作用,但在电导性动脉中不起作用,从而增加Nox1的表达和活性。因此,PDI可能是高血压建立过程中氧化应激和抵抗动脉功能改变的新参与者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号